Lisofylline, a novel antiinflammatory compound, protects mesangial cells from hyperglycemia- and angiotensin II-mediated extracellular matrix deposition (Q30311204)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Lisofylline, a novel antiinflammatory compound, protects mesangial cells from hyperglycemia- and angiotensin II-mediated extracellular matrix deposition |
scientific article |
Statements
1 reference
Lisofylline, a novel antiinflammatory compound, protects mesangial cells from hyperglycemia- and angiotensin II-mediated extracellular matrix deposition (English)
1 reference
David T Bolick
1 reference
Melissa E Hatley
1 reference
Suseela Srinivasan
1 reference
Catherine C Hedrick
1 reference
Jerry L Nadler
1 reference
28 August 2003
1 reference
Identifiers
1 reference